Cerus is dedicated to safeguarding the world’s blood supply. The INTERCEPT Blood System for Platelets remains the only CE Mark and FDA approved pathogen reduction system. The INTERCEPT Blood System for Cryoprecipitation produces Pathogen Reduced Cryoprecipitated Fibrinogen Complex (IFC), a therapeutic product for the treatment and control of bleeding.